Avicanna Inc
TSX:AVCN

Watchlist Manager
Avicanna Inc Logo
Avicanna Inc
TSX:AVCN
Watchlist
Price: 0.23 CAD 2.22%
Market Cap: 27.1m CAD

Gross Margin
Avicanna Inc

52%
Current
49%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52%
=
Gross Profit
13.2m
/
Revenue
25.5m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CA
Avicanna Inc
TSX:AVCN
27.1m CAD
52%
US
Eli Lilly and Co
NYSE:LLY
1T USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
492.4B USD
68%
CH
Roche Holding AG
SIX:ROG
263.6B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
213.7B GBP
82%
CH
Novartis AG
SIX:NOVN
212.5B CHF
76%
US
Merck & Co Inc
NYSE:MRK
262.1B USD
79%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
82%
IE
Endo International PLC
LSE:0Y5F
209B USD
68%
US
Pfizer Inc
NYSE:PFE
143.3B USD
75%
No Stocks Found

Avicanna Inc
Glance View

Market Cap
27.1m CAD
Industry
Pharmaceuticals

Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario and currently employs 18 full-time employees. The company went IPO on 2019-07-18. The firm is engaged in cannabinoid research, development, and evidence-based products for the global consumer, as well as medical and pharmaceutical market segments. The firm's scientific platform commercializes over twenty products across four market segments: Medical Cannabis & Wellness Products, CBD Derma-Cosmetic Products, Pharmaceuticals and Cannabis Raw Materials, Seeds, and Bulk Formulations. Its Medical Cannabis & Wellness Products are an advanced line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC), marketed under the RHO Phyto brand. Its CBD Derma-Cosmetic Products are marketed under the Pura H&W or Pura Earth brands. Its cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.

AVCN Intrinsic Value
0.38 CAD
Undervaluation 39%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52%
=
Gross Profit
13.2m
/
Revenue
25.5m
What is the Gross Margin of Avicanna Inc?

Based on Avicanna Inc's most recent financial statements, the company has Gross Margin of 52%.

Back to Top